India Intravenous Anesthetic Market To Find Better Growth with US$ 90.4 Million By 2027 | CAGR: 2.6%: Coherent Market Insights

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

India Intravenous Anesthetic Market, by Type (Barbiturates, Ketamine, Benzodiazepines, Propofol, and Others) and by End User (Hospitals, Clinics, and Others) is estimated to be valued at US$ 65.0 million in 2019 and is expected to exhibit a CAGR of 2.6% over the forecast period (2019-2027), as highlighted in a new report published by Coherent Market Insights.

Get FREE Sample PDF Including COVID-19 Impact Analysis: https://www.coherentmarketinsights.com/insight/request-pdf/3558

Intravenous anesthetics are referred to group of fast-acting compounds that are employed to stimulate complete sedation. Some of the important intravenous anesthetics include propofol, etomidate, ketamine, and barbiturates. Moreover, growth of the market is majorly driven by increasing number of surgeries in India, which is expected to drive growth of the India intravenous anesthetic market over the forecast period. Furthermore, increasing number of heart disease in India is one of the key factor that leads to rising number of different surgeries in India. For instance, according to the CADI Research Foundation data, in 2010, around 47 million Indians suffered from coronary artery disease (CAD) and around 60,000 coronary bypass surgeries are performed every year in India.

Additionally, increasing adoption of surgical robots made advancements in surgical procedures, which is expected to augment growth of the India intravenous anesthetic market over the forecast period. Technological advancements in surgery have led to shifting preference among populace from conventional surgeries to minimally invasive surgeries. The application of robotic technology for conducting minimally invasive surgeries has resulted in significant changes in surgical procedures. The acceptance of robotic surgeries has enhanced the number of surgeries performed in India. Thus, rising number of surgeries are expected to drive growth of the India intravenous anesthetic market over the forecast period.

Browse 13 Market Data Tables and 11 figures spread through 82 pages and in-depth TOC on ‘India intravenous anesthetic market, Forecast to 2027’

To know the latest trends and insights related to India intravenous anesthetic market press release, click the link below: https://bit.ly/2HpOEVv

Key Takeaways of the India intravenous anesthetic market:

• India intravenous anesthetic market is expected to exhibit a CAGR of 2.6% over the forecast period (2019-2027), attributed to increasing number of surgeries performed in India
• On the basis of type, propofol segment is expected to account for a major market share in the India intravenous anesthetic market, attributed to increasing adoption of propofol by Indian healthcare professionals for anesthetic procedure
• Key players operating in the India intravenous anesthetic market include AstraZeneca Plc, Fresenius Kabi, AbbVie Inc., Baxter International Inc., B. Braun Melsungen AG, Maruishi Pharmaceutical Co., Ltd, Piramal Healthcare, Hikma Pharmaceuticals, and Mylan N.V.

Apply Promo Code “STAYHOME” And Get an Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/3558

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at contact@cdnnewswire.com.